Investing.com - Financial Markets Worldwide

Nigeria expects to get its first COVID-19 vaccine doses in January

Published 16/12/2020, 19:55
© Reuters

By Felix Onuah
ABUJA, Dec 16 (Reuters) - Nigeria expects to receive its
first doses of a COVID-19 vaccine in January, the country's
health minister said on Wednesday, but officials do not yet know
which one they will get.
Africa's most populous nation has not been as hard-hit by
the coronavirus pandemic as others on the continent such as
South Africa, but it warned last week of a second wave of
COVID-19 infections. Health Minister Osagie Ehanire said that Nigeria has a
working group in place to handle vaccines, and is working with
the COVAX programme backed by the World Health Organization.
"We have 200 million citizens. We need to have a way to be
able to get enough to be able to take care of our citizens."
Nigeria is in talks with vaccine manufacturers as well as
teams in Britain and Russia, Ehanire said, adding that the
United Arab Emirates was introducing the country to the makers
of a Chinese vaccine that UAE officials had tested.
Nigeria does not at present have many facilities that can
store the Pfizer/BioNTech PFE.N 22UAy.DE shot, which must be
kept at minus 70 Celsius, Ehanire said.
While the Nigerian government is looking into the cost of
additional ultra-cold freezers, it would aim to secure a vaccine
that not only worked well but had a "good cost of storage and
cost of delivery", he added.
Nigeria had 74,132 confirmed cases of COVID-19 and 1,200
deaths as of Wednesday.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.